Clinical trial Recruiting at 2 sites Observational Ages 65 and up

How people over 65 understand their long-term medicines

Official title: Understanding Chronic Treatments by Patients Over 65 Years of Age

Run by Université de Reims Champagne-Ardenne · NCT07241299 · Data updated 2026-11-12

This project will see how well people aged 65 and older understand the chronic medications prescribed to them by their general practitioner.

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversité de Reims Champagne-Ardenne
Academic / other
Locations2 sites (Reims, Université de Reims Champagne-Ardenne and 1 other locations)
StatusRecruiting
StartedNovember 17, 2025
Main results expectedNovember 17, 2025
Study endsSeptember 5, 2026
Registry record updatedNovember 21, 2025
Trial IDNCT07241299 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are French-speaking adults aged 65 or older who visit a participating general practitioner and have at least one prescription for a medication intended to be used for more than three months, and who do not have neurocognitive disorders or legal guardianship.

Probably not a fit

Patients who are non–French-speaking, have diagnosed neurocognitive disorders, live in medical/residential care facilities, are under legal protection (guardianship/curatorship), or are consulting only for acute conditions without chronic prescriptions are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study enrolling patients aged 65 or over who consult participating general practitioners in Reims and who have at least one prescription for a treatment intended to last more than three months. Data are collected during GP consultations about patients' knowledge of their medications and related factors such as number of drugs, communication with the prescriber, and sociodemographic information. The primary goal is to describe the level of understanding of chronic treatments in this population, and secondary analyses will identify factors associated with better or worse understanding. No experimental intervention is given; results will be used to inform primary care practices and potential future interventions to improve medication understanding and adherence.

Why it matters

Potential benefit: If successful, the findings could help general practitioners improve how they explain long-term medications, reducing errors and nonadherence among older patients.

How similar studies have gone: Previous observational studies have repeatedly documented limited understanding and adherence to medications among older adults, so this study builds on established findings rather than testing a novel treatment.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Are aged 65 or over
* Consulting one of the general practitioners agreeing to participate in the study
* Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months)
* Agree to participate in the study.

Exclusion Criteria:

* Does not understand French,
* Has neurocognitive disorders
* Lives in a medical facility
* Consulting for an acute condition and whose prescription does not include chronic treatment.
* Protected by law (guardianship, curatorship, judicial protection),

Where it's running

  • Gestonnairedu CURRS
    Reims, Université de Reims Champagne-Ardenne, France
    Recruiting
  • Ufr Medecine Urca
    Reims, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.